DawMed Systems PLC
11 March 2005
FOR IMMEDIATE RELEASE 11 MARCH 2005
DAWMED SYSTEMS PLC
('DawMed' or 'the Company')
AGM STATEMENT
At today's Annual General Meeting of DawMed Systems plc ('DawMed' or 'the
Company'), the medical devices company which designs, manufactures, sells and
services washer-disinfector-dryers ('WDD') used by NHS Trust hospitals, private
hospitals and clinics, the Executive Chairman, Kevin Gilmore, commented:
'I am pleased to report that, in line with my December year-end Statement, every
Division of your Company is indicating significantly improved levels of business
compared with 2004, which I anticipate will lead to a return to profitability
this year.
'The Board has continued to concentrate on the Company's current and future
growth areas; namely Wassenburg flexible endoscope WD products, the Support
Services Division and the 'Clinic' bench top WDD. These three important areas
are seen by the Board as the key drivers to the future growth and profitability
of the business on which it intends to concentrate the Company's resources, but
the traditional business Division of large WDDs for the Sterile Services
Departments ('SSD') of hospitals is also showing a welcome increase compared
with 2004.
'It has been a highly active period so far. In the first five months of this
year alone, the Board has demonstrated the strength of its management team and
business performance through a successful fundraising of £260,000 gross,
predominantly for marketing the 'Clinic' and for working capital, followed by
the awards of two significant Hospital Trust contracts with a combined value
exceeding £1 million, one of which represents your company's largest single
contract to date comprising traditional SSD Division WDDs.
'Moreover, following our announcement that your company had received
confirmation of its Preferred Supplier Status award by the NHS for its 'Clinic'
Primary Care bench top WDD in England, the Directors received a noticeable and
encouraging level of positive interest when it exhibited the 'Clinic' at the
Arab Health Exhibition, the Middle East's largest healthcare exhibition, in
Dubai.
'The focus is now on the achievement of a good return on the past investments in
all Divisions of the Company and the optimisation of the existing and newly
emerging areas of application of the 'Clinic' bench top WDD from the platform of
your Company's healthy and established organisation and infrastructure.'
All resolutions proposed at the Annual General Meeting were duly passed.
---ENDS---
Enquiries:
DawMed Systems plc Tel: 1789 450075
Kevin Gilmore, Executive Chairman
Beaumont Cornish limited Tel: 020 7628 3396
Roland Cornish
Bishopsgate Communications Limited Tel: 020 7430 1600
Maxine Barnes
Dominic Barretto
For further information please visit DawMed's website at www.dawmed.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.